A Study of JNJ-77242113 in Healthy Japanese and Chinese Participants

NCT05062200 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JNJ-77242113
DRUG: Placebo

Sponsor

Janssen Pharmaceutical K.K.